BioSpace News Archive

BeyondSpring Inc. announced that the Company will report its fourth-quarter and full-year 2019 financial results and host an operational update conference call on Thursday, April 30, 2020, at 8 a.m. Eastern Time..

Parkview Health and global health service company Cigna announced they have extended their contract and will provide in-network access at a reduced cost for Cigna customers at Parkview hospitals.

For a patient with a complex wound, debridement is the first step in what can be a long process to healing.

- Grant Will Support an On-going Clinical Evaluation of Lead Investigational Drug PTI-125 in Alzheimer’s Disease -

Hope Biosciences Stem Cell Research Foundation (HBSCRF) successfully completes the first ten treatments for immune support against COVID-19. This is the first of three FDA-approved clinical trials targeting COVID-19 that the foundation is executing. The first study is providing autologous, adipose-derived mesenchymal stem cells ( HB-adMSCs ) to patients who have alr

Additional analyses from clinical trials may further aid in identifying the appropriate patients for Vitrakvi® (larotrectinib), including a presentation on patient outcomes by prior therapy and performance status Featured research includes an oral presentation in the Plenary Session on efficacy and safety outcomes in patients with NTRK gene fusions or other alterations Structure and functional characterization of investigational sma

Demand for mental health tools and services skyrockets; SAMSHA crisis hotline reported 9 times the number of requests for mental health crisis support in March Genomind’s mental health tools were shown to reduce emergency room visits by 40% and inpatient hospitalizations by 58% i Recent health plan contracts provide in-network coverage and significant discounting of Genomind Professional PGx Express for almost 40 million subscribers

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), an oncology company developing innovative medicines and artificial intelligence to find, fight and follow cancer, today announced that it will host a conference call and webcast to review first quarter ended March 31, 2020 financial results on Thursday, May 7, 2020, at 8:30 a.m. ET. To participate, please dial (877) 250-8889 (domestic) or (720) 545-0001 (international) and reference conference ID 735

Daxor Corporation, an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, announced that the United States Department of Defense has awarded the Company a $1.1 million contract for the development and deployment of a small, portable, highly accurate, battery-powered Blood Volume Analyzer.

In response to the need for critical care during the COVID-19 crisis, Carestream Health has increased production of its portable diagnostic imaging systems.